SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for iQIYI, (IQ) — Feb 23, 2018

iQIYI, Inc.
Date: Feb. 23, 2018 · CIK: 0001722608 · Accession: 0000000000-18-006059

AI Filing Summary & Sentiment

Referenced dates: February 2, 2018

Date
February 23, 2018
Author
/s/ Justin Dobbie
Form
UPLOAD
Company
iQIYI, Inc.

Letter

Mail Stop 3561 February 23, 2018 Dr. Yu Gong Chief Executive Officer iQIYI, Inc. 9/F, iQIYI Innovation Building No. 2 Haidian North First Street Haidian District, Beijing 100080 People’s Republic of China

Re: iQIYI, Inc. Amendment No. 2 to Draft Registration Statement on Form F-1 Submitted February 12 , 2018 CIK No. 0001722608

Dear Dr. Gong :

We have reviewed your amended draft registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing the information you provide in response to these comments and your amended draft registration statement or filed registration statement, we may have additional comments. Unless otherw ise noted, references to prior comments refer to comments in our letter dated February 2, 2018.

Management’s Discussion and Analysis

Non-GAAP Measures, page 87

1. We note your disclosure that the non -GAAP measures exclude items that are “infrequent or unus ual in nature.” Please note Item 10(e) of Regulation S -K prohibits adjusting a non-GAAP financial performance measure to eliminate or smooth items identified as infrequent or unusual when the nature of the charge or gain is such that it is reasonably likely to recur within two years or there was a similar charge or gain within the prior two

Dr. Yu Gong iQIYI, Inc. February 23, 2018 Page 2

years. Please revise your disclosure as appropriate. Also r efer to Question 102.03 of the staff’s Compliance and Disclosure Interpretations “Non -GAAP Financial Measur es” (“C&DI”) for guidance.

2. Your disclosure states the no n-GAAP measures are used to measure both your performance and your liquidity. In regards to the measure being presented as a liquidity measure, please tell us your consideration of also providing a reconciliation to operating cash flow as the most directly comparable GAAP measure to comply with Item 10(e)(1)(i)(B) of Regulation S -K.

Notes to Consolidated Financial Statements

19. Loss Per Share , page F -48

3. Please revise or clarify to us your disclosure on page F -48 which states upon “automatic conversion of all of the Company’s redeemable convertible preferred shares… and all outstanding shares are re -designated into 416,314,037 Class A ordinary shares and 2,640,621,681 Class B ordinary shares” with your tabular disclosure on page F -49 which reflects 1.2B Class A ordinary shares and 2. 8B Class B ordinary shares upon the automatic conversion of the redeemable convertible preferred shares.

You may contact Abe Friedman at (202) 551 -8298 or Theresa Brillant at (202) 551 -3307 if you have questions regarding comments on the financial statements and related matters. Please contact J. Nolan McWilliams, Attorney -Advisor , at (202) 551 -3217 or me at (202) 551 - 3469 with any other questions.

Sincerely,
/s/ Justin Dobbie

Show Raw Text
Mail Stop 3561
February 23, 2018

Dr. Yu Gong
Chief Executive Officer
iQIYI, Inc.
9/F, iQIYI Innovation Building
No. 2 Haidian North First Street
Haidian District, Beijing 100080
People’s Republic of China

Re: iQIYI, Inc.
Amendment No. 2 to
Draft Registration Statement on Form F-1
Submitted February 12 , 2018
  CIK No. 0001722608

Dear Dr. Gong :

We have reviewed your amended draft registration statement  and have the following
comments.  In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.

Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR.  If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.

After reviewing the information you provide in response to these  comments  and your
amended draft registration statement or filed registration statement,  we may have  additional
comments.   Unless otherw ise noted, references to prior comments refer to comments in our letter
dated February 2, 2018.

Management’s Discussion and Analysis

Non-GAAP Measures, page 87

1. We note your disclosure that the non -GAAP measures exclude  items that are “infrequent
or unus ual in nature.”   Please note Item 10(e) of Regulation S -K prohibits adjusting a
non-GAAP financial performance measure to eliminate or smooth items identified as
infrequent or unusual when the nature of the charge or gain is such that it is reasonably
likely to recur within two years or there was a similar charge or gain within the prior two

Dr. Yu Gong
iQIYI, Inc.
February 23, 2018
Page 2

 years.  Please revise your disclosure as appropriate.  Also r efer to Question 102.03 of the
staff’s Compliance and Disclosure Interpretations “Non -GAAP Financial Measur es”
(“C&DI”) for guidance.

2. Your disclosure states the no n-GAAP measures are used to measure both your
performance and your liquidity.  In regards to the measure being presented as a liquidity
measure, please tell us your consideration of also providing a reconciliation  to operating
cash flow as the most directly comparable  GAAP measure to comply with Item
10(e)(1)(i)(B) of Regulation S -K.

Notes to Consolidated Financial Statements

19. Loss Per Share , page F -48

3. Please revise or clarify to us your disclosure on page F -48 which states upon “automatic
conversion of all of the Company’s redeemable convertible preferred shares…  and all
outstanding shares are re -designated into 416,314,037 Class A ordinary shares and
2,640,621,681 Class B ordinary shares” with your tabular disclosure on page F -49 which
reflects 1.2B  Class A ordinary shares and 2. 8B Class B ordinary shares upon the
automatic conversion of the redeemable convertible preferred shares.

You may contact Abe Friedman  at (202) 551 -8298  or Theresa Brillant  at (202) 551 -3307
if you have questions regarding comments on the financial statements and related matters.
Please contact J. Nolan McWilliams, Attorney -Advisor , at (202) 551 -3217  or me at (202) 551 -
3469  with any other questions.

Sincerely,

 /s/ Justin Dobbie

Justin Dobbie
Legal Branch Chief
Office of Transportation and Leisure

cc: Z. Julie Gao, Esq.
 Skadden, Arps, Slate, Meagher & Flom LLP